• Eyüp Çetin, Tunahan Samcak, Ömer Faruk Keleş, İlker Ünlü, Mehmet Edip Akyol, and Özkan Arabacı.
• Department of Neurosurgery, Health Sciences University Haydarpaşa Numune Training and Research Hospital, İstanbul-Türkiye.
• Ulus Travma Acil Cerrahi Derg. 2023 Dec 1; 29 (12): 132913341329-1334.

BackgroundThis experimental study was designed to investigate the histopathological and immunohistochemical effects of Shilajit in rats with experimentally induced spinal cord injury (SCI).MethodsThe rats were divided into three groups: Control group: The group in which spinal cord damage was created but no drug was administered. Low-dose group: This is the group in which intraperitoneal Shilajit is given at a dose of 150 mg/kg at the 1st h, 1st day, 2nd day, and 3rd day after spinal cord damage was induced. High-dose group: This is the group in which intraperitoneal Shilajit is given at a dose of 250 mg/kg at the 1st h, 1st day, 2nd day, and 3rd day after spinal cord damage was induced. Thin sections taken from the spinal cord after euthanasia were sent for histopathological and immunohistochemical examination.ResultsHistopathological examination of the high-dose group showed lower amounts of morphological findings compared to the low-dose group and control group. While a significant CD68 immune reaction was observed in the control group of rats with spinal injury, the positive immune reaction was found to be significantly decreased in the Shilajit-applied groups.ConclusionIt is thought that the use of Shilajit in SCI will reduce the effects of secondary damage in SCI and that its administra-tion to such patients will have positive effects on the results.

8 keywords...

hide…